This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiederkehr, A. Articles by Wollheim, C. B. Search for Related Content PubMed PubMed Citation Articles by Wiederkehr, A. Articles by Wollheim, C. B.

Minireview: Implication of Mitochondria in Insulin Secretion and Action

University of Geneva Medical Center, Geneva, Switzerland

Address all correspondence and requests for reprints to: Dr. Claes B. Wollheim, Department of Cell Physiology and Metabolism, University Medical Center, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland. E-mail: claes.wollheim{at}medecine.uinge.ch.

Mitochondria are essential for intermediary metabolism as well as energy production in the cell. Their aerobic metabolism permits oxidation of glucose and fatty acids for the generation of ATP and other intermediates that are exchanged with the cytoplasm for various biosynthetic and secretory processes. In the pancreatic ß-cell, glucose carbons are quantitatively funneled to the mitochondria, where signals for the initiation and potentiation of insulin secretion are generated. After mitochondrial activation, the plasma membrane is depolarized with ensuing cytosolic calcium transients and exocytosis of insulin. Calcium also acts in a feed-forward manner on mitochondrial metabolism, which contributes to sustained second phase insulin secretion. Patients with mitochondrial diabetes and a corresponding mouse model display defective glucose-stimulated insulin secretion and reduced ß-cell mass, leading to overt diabetes. Normal mitochondrial activity appears to be equally important in the action of insulin on its target tissues. The development of insulin resistance may involve impairment of glucose oxidation after short exposure to increased levels of circulating free fatty acids. Insulin resistance in the elderly and in relatives of type 2 diabetic patients has also been associated with mitochondrial dysfunction. Both prevention and treatment of type 2 diabetes should focus on mitochondrial targets for the improvement of nutrient-stimulated insulin secretion and their utilization in peripheral tissues.

This article has been cited by other articles:

				T. Ueda, T. Furusawa, T. Kurahashi, L. Tessarollo, and M. Bustin The Nucleosome Binding Protein HMGN3 Modulates the Transcription Profile of Pancreatic {beta} Cells and Affects Insulin Secretion Mol. Cell. Biol., October 1, 2009; 29(19): 5264 - 5276. [Abstract] [Full Text] [PDF]

				M. M. Lindroos, K. Majamaa, A. Tura, A. Mari, K. K. Kalliokoski, M. T. Taittonen, P. Iozzo, and P. Nuutila m.3243A>G Mutation in Mitochondrial DNA Leads to Decreased Insulin Sensitivity in Skeletal Muscle and to Progressive {beta}-Cell Dysfunction Diabetes, March 1, 2009; 58(3): 543 - 549. [Abstract] [Full Text] [PDF]

				C. Rosker, G. Meur, E. J. A. Taylor, and C. W. Taylor Functional Ryanodine Receptors in the Plasma Membrane of RINm5F Pancreatic {beta}-Cells J. Biol. Chem., February 20, 2009; 284(8): 5186 - 5194. [Abstract] [Full Text] [PDF]

				S. Puri, D. A. Cano, and M. Hebrok A Role for von Hippel-Lindau Protein in Pancreatic {beta}-Cell Function Diabetes, February 1, 2009; 58(2): 433 - 441. [Abstract] [Full Text] [PDF]

				P. Marmol, B. Pardo, A. Wiederkehr, A. del Arco, C. B. Wollheim, and J. Satrustegui Requirement for Aralar and Its Ca2+-binding Sites in Ca2+ Signal Transduction in Mitochondria from INS-1 Clonal {beta}-Cells J. Biol. Chem., January 2, 2009; 284(1): 515 - 524. [Abstract] [Full Text] [PDF]

				K.-S. Park, A. Wiederkehr, C. Kirkpatrick, Y. Mattenberger, J.-C. Martinou, P. Marchetti, N. Demaurex, and C. B. Wollheim Selective Actions of Mitochondrial Fission/Fusion Genes on Metabolism-Secretion Coupling in Insulin-releasing Cells J. Biol. Chem., November 28, 2008; 283(48): 33347 - 33356. [Abstract] [Full Text] [PDF]

				A.M. Hall, R.J. Unwin, M.G. Hanna, and M.R. Duchen Renal function and mitochondrial cytopathy (MC): more questions than answers? QJM, October 1, 2008; 101(10): 755 - 766. [Abstract] [Full Text] [PDF]

				H.-E. Kim, S.-E Choi, S.-J. Lee, J.-H. Lee, Y.-J. Lee, S. S. Kang, J. Chun, and Y. Kang Tumour necrosis factor-{alpha}-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca2+ influx J. Endocrinol., September 1, 2008; 198(3): 549 - 560. [Abstract] [Full Text] [PDF]

				H. Lu, Y. Yang, E. M. Allister, N. Wijesekara, and M. B. Wheeler The Identification of Potential Factors Associated with the Development of Type 2 Diabetes: A Quantitative Proteomics Approach Mol. Cell. Proteomics, August 1, 2008; 7(8): 1434 - 1451. [Abstract] [Full Text] [PDF]

				J.-a Kim, Y. Wei, and J. R. Sowers Role of Mitochondrial Dysfunction in Insulin Resistance Circ. Res., February 29, 2008; 102(4): 401 - 414. [Abstract] [Full Text] [PDF]

				N. H. McClenaghan Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes Exp Physiol, May 1, 2007; 92(3): 481 - 496. [Abstract] [Full Text] [PDF]

				S. E. Wiley, A. N. Murphy, S. A. Ross, P. van der Geer, and J. E. Dixon MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity PNAS, March 27, 2007; 104(13): 5318 - 5323. [Abstract] [Full Text] [PDF]